Massive infiltration of bone marrow in colon carcinoma after treatment with activated protein C

被引:9
|
作者
Pleyer, Lisa
Went, Philip
Russ, Gudrun
Prinz, Erika
Faber, Viktoria
Roewert, Hans-Joachim
Karlbauer, Renate
Greil, Richard
机构
[1] Private Med Paracelsus Univ Salzburg, Med Dept Hematol Med Oncol Hemostaseol Rheumatol, A-5020 Salzburg, Austria
[2] Private Med Paracelsus Univ Salzburg, Dept Pathol, A-5020 Salzburg, Austria
[3] Private Med Paracelsus Univ Salzburg, Dept Anesthesiol, A-5020 Salzburg, Austria
[4] Univ Basel Hosp, Dept Pathol, CH-4031 Basel, Switzerland
关键词
activated protein C; bone marrow infiltration; colorectal cancer; sepsis;
D O I
10.1007/s00508-007-0774-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We present an unusual case of localized colorectal carcinoma complicated by sepsis which was treated with activated protein C (APC). Shortly after treatment the patient developed symptomatic metastases to the bone marrow (BM). Destruction of bones by colorectal cancer (CRC) is rare, although BM micrometastases are frequently observed. However, overt symptomatic BM metastasis is an exotic rarity. APC interacts with molecules and modulates pathways that are unquestionably involved in tumorigenesis and formation of metastases. Therefore a possible contributory role of the anti-inflammatory and immunomodulatory therapy in the rapid evolution of the disease cannot be excluded. Questions concerning the relevance and contribution of sepsis, treatment with APC, exquisitely high levels of non-thrombosis-associated D-dimer and CA19-9 to this highly uncommon course of disease are discussed. The lesson learned from this case is that APC may have contributed to the massive invasion of BM by colonic cancer cells in our patient and that APC should therefore be used with extreme restraint in patients with potentially curable cancer.
引用
收藏
页码:254 / 258
页数:5
相关论文
共 50 条
  • [31] Can troponin identify those critically ill septic patients who would benefit most from activated protein C treatment?
    Fernandes, Constantino Jose, Jr.
    CRITICAL CARE MEDICINE, 2009, 37 (01) : 367 - 368
  • [32] The Importance of Release of Proinflammatory Cytokines, ROS, and NO in Different Stages of Colon Carcinoma Growth and Metastasis After Treatment With Cytotoxic Drugs
    Paduch, Roman
    Kandefer-Szerszen, Martyna
    Piersiak, Tomasz
    ONCOLOGY RESEARCH, 2010, 18 (09) : 419 - 436
  • [33] Effect of factor V Leiden polymorphism in severe sepsis and on treatment with recombinant human activated protein C
    Yan, SB
    Nelson, DR
    CRITICAL CARE MEDICINE, 2004, 32 (05) : S239 - S246
  • [34] Activated Protein C Is Neuroprotective and Mediates New Blood Vessel Formation and Neurogenesis After Controlled Cortical Impact
    Petraglia, Anthony L.
    Marky, Andrew H.
    Walker, Corey
    Thiyagarajan, Meenakshisundaram
    Zlokovic, Berislav V.
    NEUROSURGERY, 2010, 66 (01) : 165 - 171
  • [35] Pre-Treatment Levels of C-Reactive Protein and Squamous Cell Carcinoma Antigen for Predicting the Aggressiveness of Pharyngolaryngeal Carcinoma
    Chen, Hsuan-Ho
    Wang, Hung-Ming
    Fan, Kang-Hsing
    Lin, Chien-Yu
    Yen, Tzu-Chen
    Liao, Chun-Ta
    Chen, I-How
    Kang, Chung-Jan
    Huang, Shiang-Fu
    PLOS ONE, 2013, 8 (01):
  • [36] Protective effects of activated protein C (APC) on free groin flaps after secondary venous stasis in the rat model
    Wallmichrath, J.
    Knab, R.
    Baumeister, R. G. H.
    Holzbach, T.
    Giunta, R. E.
    Frick, A.
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2015, 59 (04) : 335 - 343
  • [37] The Next Generation of Sepsis Clinical Trial Designs: What Is Next After the Demise of Recombinant Human Activated Protein C?
    Opal, Steven M.
    Dellinger, R. Phillip
    Vincent, Jean-Louis
    Masur, Henry
    Angus, Derek C.
    CRITICAL CARE MEDICINE, 2014, 42 (07) : 1714 - 1721
  • [38] C-reactive protein response patterns after antibiotic treatment among children with scalds
    Steinvall, Ingrid
    Karlsson, Matilda
    Elmasry, Moustafa
    BURNS, 2018, 44 (03) : 718 - 723
  • [39] A comparative double-blind randomized trial of activated protein C and unfractionated heparin in the treatment of disseminated intravascular coagulation
    Aoki, N
    Matsuda, T
    Saito, H
    Takatsuki, K
    Okajima, K
    Takahashi, H
    Takamatsu, J
    Asakura, H
    Ogawa, N
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 75 (05) : 540 - 547
  • [40] A Comparative Double-Blind Randomized Trial of Activated Protein C and Unfractionated Heparin in the Treatment of Disseminated Intravascular Coagulation
    Nobuo Aoki
    Tamotsu Matsuda
    Hidehiko Saito
    Kiyoshi Takatsuki
    Kenji Okajima
    Hoyu Takahashi
    Junki Takamatsu
    Hidesaku Asakura
    Nobuya Ogawa
    International Journal of Hematology, 2002, 75 : 540 - 547